Demethylating agent 5-aza-2′-deoxycytidine activates HLA-G expression in human leukemia cell lines

被引：25

作者：

Polakova, K. ^{[2
]}

Bandzuchova, E. ^{[3
]}

Kuba, D. ^{[3
]}

Russ, G. ^{[1
]}

机构：

[1] Slovak Acad Sci, Inst Virol, Bratislava 84505, Slovakia

[2] Slovak Acad Sci, Canc Res Inst, Bratislava 84505, Slovakia

[3] Slovak Med Univ, Bratislava, Slovakia

来源：

LEUKEMIA RESEARCH | 2009年 / 33卷 / 04期

关键词：

HLA-G; Leukemia cells; Demethylation; 5-Aza-2 '-deoxycytidine; CHRONIC LYMPHOCYTIC-LEUKEMIA; TUMOR-CELLS; G GENE; PROMOTER REGION; CANCER; DNA; DECITABINE; INHIBITORS; PROTEINS;

D O I：

10.1016/j.leukres.2008.08.003

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

HLA-G is a non-classical HLA class I antigen primarily expressed in the extravillous cytotrophoblast. HLA-G can also be expressed at some pathological circumstances and may thus contribute to inhibition of efficient immune responses. Complex regulation of HLA-G expression also involves epigenetic mechanisms as DNA methylation. Here we demonstrate that treatment with demethylating agent 5-aza-2'-deoxycytidine (AdC) resulted in HLA-G transcription in 18 out of 20 examined leukemia cell lines. FILA-G protein synthesis was detected in 10 cell lines expressing significant level of HLA-G transcripts following AdC treatment. (C) 2008 Elsevier Ltd. All rights reserved

引用

页码：518 / 524

页数：7

共 50 条

[31] DNA demethylating therapy in MDS:: The experience with 5-AZA-2′-deoxycytidine (decitabine).
Wijermans, P
Luebbert, M
Verhoef, G
Bosly, A
Ravoet, C
Andre, M
Ferrant, A
Haak, H
BLOOD, 1999, 94 (10) : 306A - 306A
[32] EXPRESSION OF THE MAGE-1 TUMOR-ANTIGEN IS UP-REGULATED BY THE DEMETHYLATING AGENT 5-AZA-2'-DEOXYCYTIDINE
WEBER, J
SALGALLER, M
SAMID, D
JOHNSON, B
HERLYN, M
LASSAM, N
TREISMAN, J
ROSENBERG, SA
CANCER RESEARCH, 1994, 54 (07) : 1766 - 1771
[33] MODULATION OF HLA-DR ANTIGENS EXPRESSION IN HUMAN MYELOID-LEUKEMIA CELLS BY CYTARABINE AND 5-AZA-2'-DEOXYCYTIDINE
PINTO, A
MAIO, M
ATTADIA, V
ZAPPACOSTA, S
CIMINO, R
LANCET, 1984, 2 (8407): : 867 - 868
[34] The DNA demethylating agent 5-aza-2′-deoxycytidine induces expression of NY-ESO-1 and other cancer/testis antigens in myeloid leukemia cells
Almstedt, Maika
Blagitko-Dorfs, Nadja
Duque-Afonso, Jesus
Karbach, Julia
Pfeifer, Dietmar
Jaeger, Elke
Luebbert, Michael
LEUKEMIA RESEARCH, 2010, 34 (07) : 899 - 905
[35] Mechanisms of naturally occurring resistance to 5-aza-2'deoxycytidine in human cancer cell lines
Qin, Taichun
Jelinek, Jaroslav
Issa, Jean-Pierre
MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3398S - 3399S
[36] THE DNA DEMETHYLATING AGENT 5-AZA-2′-DEOXYCYTIDINE INDUCES EXPRESSION OF NY-ESO-1 AND OTHER CANCER/TESTIS ANTIGENS IN MYELOID LEUKEMIA CELLS
Blagitko-Dorfs, N.
Almstedt, M.
Duque-Afonso, J.
Karbach, J.
Pfeifer, D.
Jaeger, E.
Luebbert, M.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 306 - 307
[37] Pharmacodynamic effects in patients treated with 6 hour infusion of the demethylating agent 5-aza-2′deoxycytidine (decitabine).
Brown, R
Appleton, K
Plumb, JA
McCormick, C
Lee, C
Barrett, S
Tang, A
Schaetzlein, A
Kaye, SB
Judson, I
McKay, HJ
CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9071S - 9072S
[38] 5-aza-2′-deoxycytidine sensitizes hepatoma and pancreatic cancer cell lines
Kanda, T
Tada, M
Imazeki, F
Yokosuka, O
Nagao, K
Saisho, H
ONCOLOGY REPORTS, 2005, 14 (04) : 975 - 979
[39] Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine (vol 7, pg 523, 2005)
Yan, WH
Lin, AF
Chang, CC
Ferrone, S
CELL RESEARCH, 2005, 15 (08) : 678 - 678
[40] Synergistic induction of cell death and apoptosis by the histone deacetylase inhibitor vorinostat and the demethylating agent 5-aza-2′-deoxycytidine in multiple myeloma
Jost, Edgar
Schubert, Claudia
Brummendorf, Tim H.
Galm, Oliver
CANCER RESEARCH, 2010, 70

← 1 2 3 4 5 →